Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ACETAL-TC
- Development stage
- Unknown
- Lead developer
- Zytras Life Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ACETAL-TC is a fixed-dose combination generic pharmaceutical formulation marketed by Zytras Life Sciences, an Indian PCD (Propaganda Cum Distribution) pharma company. The product is composed of **aceclofenac**, a non-steroidal anti-inflammatory drug (NSAID), and **thiocolchicoside**, a semi-synthetic muscle relaxant. Aceclofenac works by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for the synthesis of prostaglandins that mediate pain, fever, and inflammation. Thiocolchicoside acts as a competitive antagonist at gamma-aminobutyric acid (GABA) type A and glycine receptors in the central nervous system, providing muscle relaxant effects by reducing muscle stiffness and spasms without significant sedative properties. This combination is primarily indicated for the symptomatic treatment of acute painful muscle spasms associated with musculoskeletal conditions such as low back pain, neck pain, and post-operative pain.
- Brand names
- ACETAL-TC
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on ACETAL-TC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACETAL-TC.